DK12487D0 - Omega-((heterocyclyl)-alkyl)-benz(c,d)-indol-2-aminer og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler - Google Patents
Omega-((heterocyclyl)-alkyl)-benz(c,d)-indol-2-aminer og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidlerInfo
- Publication number
- DK12487D0 DK12487D0 DK012487A DK12487A DK12487D0 DK 12487 D0 DK12487 D0 DK 12487D0 DK 012487 A DK012487 A DK 012487A DK 12487 A DK12487 A DK 12487A DK 12487 D0 DK12487 D0 DK 12487D0
- Authority
- DK
- Denmark
- Prior art keywords
- benz
- indol
- omega
- alkyl
- amines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/818,315 US4728663A (en) | 1986-01-13 | 1986-01-13 | N-[(1H-imidazol-1-yl)alkyl]benz[cd]-indol-2-amines and use in inhibiting thromboxane synthetase enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK12487D0 true DK12487D0 (da) | 1987-01-12 |
| DK12487A DK12487A (da) | 1987-07-14 |
Family
ID=25225236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK012487A DK12487A (da) | 1986-01-13 | 1987-01-12 | Omega-((heterocyclyl)-alkyl)-benz(c,d)-indol-2-aminer og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4728663A (da) |
| EP (1) | EP0230035B1 (da) |
| JP (1) | JPS62215582A (da) |
| KR (1) | KR900002756B1 (da) |
| AT (1) | ATE112771T1 (da) |
| AU (1) | AU604223B2 (da) |
| CA (1) | CA1317948C (da) |
| DE (1) | DE3650096D1 (da) |
| DK (1) | DK12487A (da) |
| FI (1) | FI92063C (da) |
| HU (1) | HU198924B (da) |
| NO (1) | NO168035C (da) |
| NZ (1) | NZ218879A (da) |
| PH (1) | PH23606A (da) |
| ZA (1) | ZA87185B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081131A (en) * | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| IT1229237B (it) * | 1989-05-08 | 1991-07-26 | Prodotti Formenti | Sali di (2-(piridil)etil) metilammina |
| US5079247A (en) * | 1990-03-14 | 1992-01-07 | American Cyanamid Company | N1 -substituted benz(cd)indol-2-imine compounds as cardiovascular agents |
| GB9127304D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
| GB9312893D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| DE19628893A1 (de) * | 1996-07-17 | 1998-01-22 | Basf Ag | Verwendung von 1-Amidoalkylimidazolen als Korrosionsinhibitoren in der petrochemischen Industrie und Verfahren zu deren Herstellung |
| US6077460A (en) * | 1996-07-17 | 2000-06-20 | Basf Aktiengesellschaft | Corrosion inhibition |
| BR9907170A (pt) | 1998-04-02 | 2000-12-26 | Reynolds Tobacco Co R | Composições farmacêuticas e métodos para uso |
| US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
| US6403581B1 (en) | 2000-01-19 | 2002-06-11 | American Cyanamid Company | Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives |
| CN105985282B (zh) * | 2015-01-28 | 2020-12-08 | 中国科学院广州生物医药与健康研究院 | 一种2-氧代-1,2-二氢苯并[cd]吲哚类化合物及其应用 |
| CN114349684B (zh) * | 2022-01-19 | 2023-03-28 | 西南林业大学 | 一种苯并[c,d]吲哚亚胺衍生物的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1388599A (fr) * | 1963-04-20 | 1965-02-05 | Bayer Ag | Colorants nouveaux et procédé pour les fabriquer et les appliquer |
| DE2608020A1 (de) * | 1976-02-27 | 1977-09-01 | Bayer Ag | Naphthostyrilfarbstoffe |
| DE2733440A1 (de) * | 1976-08-03 | 1978-02-09 | Sandoz Ag | Benz eckige klammer auf cd eckige klammer zu indolyl-derivate, ihre verwendung und herstellung |
| US4261896A (en) * | 1979-11-23 | 1981-04-14 | American Cyanamid Company | 1-Substituted-2-(substituted-imino)-1H-1,2-dihydrobenz[cd]indoles |
| US4259490A (en) * | 1980-06-23 | 1981-03-31 | American Cyanamid Company | 2-(Substituted amino)benz[cd]indoles |
-
1986
- 1986-01-13 US US06/818,315 patent/US4728663A/en not_active Expired - Fee Related
- 1986-12-22 AT AT86117878T patent/ATE112771T1/de not_active IP Right Cessation
- 1986-12-22 DE DE3650096T patent/DE3650096D1/de not_active Expired - Lifetime
- 1986-12-22 EP EP86117878A patent/EP0230035B1/en not_active Expired - Lifetime
-
1987
- 1987-01-09 NZ NZ218879A patent/NZ218879A/en unknown
- 1987-01-09 CA CA000527024A patent/CA1317948C/en not_active Expired - Fee Related
- 1987-01-12 NO NO870111A patent/NO168035C/no unknown
- 1987-01-12 PH PH34708A patent/PH23606A/en unknown
- 1987-01-12 AU AU67493/87A patent/AU604223B2/en not_active Ceased
- 1987-01-12 DK DK012487A patent/DK12487A/da unknown
- 1987-01-12 KR KR1019870000168A patent/KR900002756B1/ko not_active IP Right Cessation
- 1987-01-12 ZA ZA87185A patent/ZA87185B/xx unknown
- 1987-01-12 HU HU8791A patent/HU198924B/hu not_active IP Right Cessation
- 1987-01-12 FI FI870100A patent/FI92063C/fi not_active IP Right Cessation
- 1987-01-13 JP JP62004198A patent/JPS62215582A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0230035A3 (en) | 1990-01-10 |
| FI92063C (fi) | 1994-09-26 |
| DE3650096D1 (de) | 1994-11-17 |
| CA1317948C (en) | 1993-05-18 |
| NO168035B (no) | 1991-09-30 |
| ZA87185B (en) | 1988-07-27 |
| NO870111D0 (no) | 1987-01-12 |
| FI870100A0 (fi) | 1987-01-12 |
| KR900002756B1 (ko) | 1990-04-28 |
| EP0230035A2 (en) | 1987-07-29 |
| NO168035C (no) | 1992-01-08 |
| JPS62215582A (ja) | 1987-09-22 |
| FI870100A (fi) | 1987-07-14 |
| DK12487A (da) | 1987-07-14 |
| NZ218879A (en) | 1990-12-21 |
| KR870007158A (ko) | 1987-08-17 |
| AU6749387A (en) | 1987-07-16 |
| NO870111L (no) | 1987-07-14 |
| EP0230035B1 (en) | 1994-10-12 |
| HUT43059A (en) | 1987-09-28 |
| PH23606A (en) | 1989-09-11 |
| ATE112771T1 (de) | 1994-10-15 |
| US4728663A (en) | 1988-03-01 |
| FI92063B (fi) | 1994-06-15 |
| HU198924B (en) | 1989-12-28 |
| AU604223B2 (en) | 1990-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI88037B (fi) | Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat | |
| DK12487D0 (da) | Omega-((heterocyclyl)-alkyl)-benz(c,d)-indol-2-aminer og farmakologisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler | |
| LV10575A (lv) | Izoksazoi-4-karbonskabes amids un hidroksialkiliden-cianetikskabes amids sos savienojumus saturosi astniecibas lidzekli un to pielietojums | |
| SE9504661D0 (sv) | New compounds | |
| FI941523A (fi) | Menetelmä terapeuttisesti käyttökelpoisen 1-(beta-D-arabinofuranosyyli)-5-propynyyliurasiilin farmaseuttisesti hyväksyttävän emässuolan valmistamiseksi | |
| NO872589D0 (no) | Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon. | |
| NO20030301L (no) | Nye heteroarylderivater og anvendelse derav som farmasöytika | |
| DE69021501D1 (de) | Anti-entzündende 4-aminophenol-derivate. | |
| DK58084D0 (da) | Benzazocinon- og benzazoninonderivater og salte deraf samt deres fremstilling og anvendelse | |
| SE8900192D0 (sv) | Dideoxididehydrokarbocykliska nukleosider | |
| NO324229B1 (no) | 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| DK53285A (da) | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme | |
| DK23289A (da) | Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse | |
| FI872255A (fi) | Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi | |
| DK0479093T3 (da) | Oligosaccharidderivater og deres anvendelse som lægemidler | |
| DK1015437T3 (da) | Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler | |
| SE9504662D0 (sv) | New compounds | |
| BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
| FI99013B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi | |
| FI911285A0 (fi) | Antipsykotiska bicykliska 4-/4-(3-bensisotiazolyl)-1-piperazinyl/butylbryggimider. | |
| FI871479A (fi) | Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi | |
| NO940633L (no) | Nye forbindelser | |
| ES2063784T3 (es) | Procedimiento para la preparacion de derivados de pirrolizina. | |
| NO890328L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater. |